UnitedHealth Group

8 hours ago · fool.com

UnitedHealth's stock has been doing much better this year due to improved financial results. Costs have been coming down, and the company raised its guidance in July.

2 days ago · seekingalpha.com

I still view UnitedHealth as a fully playable recovery, with MCR improving from 89.4% to 86.7% and 2026 EPS guidance already raised twice. Management is deliberately giving up lower-quality membership to rebuild margins, while operating cash flow guidance has increased from >$18B to ~$24B. The broader health care setup also looks attractive, with the sector heavily lagging the S&P 500 and a more defensive macro backdrop developing.

3 days ago · zacks.com

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

3 days ago · zacks.com

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

3 days ago · benzinga.com

On CNBC's “Halftime Report Final Trades,” Kevin Simpson, founder and CEO of Capital Wealth Planning, picked UnitedHealth Group Incorporated (NYSE:UNH).

4 days ago · zacks.com

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

4 days ago · benzinga.com

On CNBC's “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, picked The Charles Schwab Corporation (NYSE:SCHW).

5 days ago · finbold.com

The next quarterly UnitedHealth (NYSE: UNH) dividend is coming next week, on Tuesday, September 22, 2026, when all shareholders of record as of the close of business on September 14, 2026, will receive $2.32 per share.

5 days ago · businesswire.com

--(BUSINESS WIRE)--UnitedHealth Group will release its third quarter 2026 financial results on Tuesday, October 13, 2026, before the market opens.

6 days ago · seekingalpha.com

UnitedHealth Group (UNH) remains a buy, with attractive valuation and solid fundamentals despite recent underperformance versus the S&P 500. Q2 results delivered an earnings triple play: beats on revenue and EPS, plus raised FY 2026 guidance; medical loss ratio held at 86.7%. Consensus EPS upgrades (24 upgrades, zero downgrades) and a 6.9% FCF yield support confidence in UNH's long-term growth trajectory.